Si Hong Lu
About Si Hong Lu
Si Hong Lu is a Senior Scientist at CellMax Life, specializing in cancer biology and microfluidics. He holds a Ph.D. from the National Defense Medical Center and has extensive academic experience in medical technology and immunology.
Work at CellMax Life
Si Hong Lu has been employed at CellMax Life as a Senior Scientist since 2016. In this role, Lu contributes to research and development efforts focused on innovative solutions in the field of cancer diagnostics. The position involves applying expertise in cancer biology and microfluidics to advance the company's mission of improving patient outcomes through early detection of cancer.
Education and Expertise
Si Hong Lu holds a Doctor of Philosophy (Ph.D.) in cancer biology from National Defense Medical Center, where research focused on circulating tumor cells and microfluidics. Prior to this, Lu earned a Master's Degree in Immunology and Diabetes from Chung Shan Medical University. Lu's academic background also includes a Bachelor's Degree in Medical Technology from Chung Shan Medical University, providing a strong foundation in medical sciences.
Background
Si Hong Lu's academic journey began at Chung Shan Medical University, where Lu completed a Bachelor's Degree in Medical Technology from 2001 to 2005. Following this, Lu pursued a Master's Degree in Immunology and Diabetes at the same institution, completing the program in 2008. Lu then continued education at National Defense Medical Center, culminating in a Ph.D. in cancer biology in 2016. During this period, Lu also worked as a Ph.D. student at Academia Sinica in Taiwan.
Achievements
Throughout the academic and professional career, Si Hong Lu has engaged in significant research related to cancer biology, particularly in the areas of circulating tumor cells and microfluidics. The work conducted during the Ph.D. program and subsequent role at CellMax Life reflects a commitment to advancing knowledge and technology in cancer diagnostics. Lu's contributions are recognized within the scientific community, particularly in the context of improving cancer detection methodologies.